Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
08/11/2010 | CN101797299A Refining method of traditional Chinese medicine composition water extract liquid containing fructus forsythiae |
08/11/2010 | CN101797294A Chinese medicinal liquid for treating dermatophytosis |
08/11/2010 | CN101797286A Chinese traditional medicine combination for alleviating wound infections and suture reaction after surgery and preparation method thereof |
08/11/2010 | CN101797281A Medicinal granules for toxin elimination and blood fat reduction |
08/11/2010 | CN101797266A Pharmaceutical composition containing quercetin and usage thereof |
08/11/2010 | CN101797264A Amphotericin B lipid complex for injection and preparation method thereof |
08/11/2010 | CN101797263A Traditional Chinese medicine composite for antibiosis and antiphlogosis |
08/11/2010 | CN101797254A Ointment for radical treatment of beriberi and preparation method |
08/11/2010 | CN101797251A Inhibitor for acetylcoenzyme A synthetase in human pathogen clostridium difficile |
08/11/2010 | CN101797246A Application of radix scutellariae and flavonoid against sub-type infection of influenza virus A (H1N1) |
08/11/2010 | CN101797241A Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol |
08/11/2010 | CN101797238A Method for preparing medicinal preparation for releasing rifampicin on upper part of small intestine and characteristics of medicinal preparation |
08/11/2010 | CN101797231A Method for controlling quality of Ceftezole sodium used for injection |
08/11/2010 | CN101796970A Sterilizing antiviral influenza-preventing spraying agent prepared from traditional Chinese medicine and production method thereof |
08/11/2010 | CN101485673B Roxithromycin and ambroxol hydrochloride dispersible tablets |
08/11/2010 | CN101301476B Hydrophobic cyclodextrin clathrate and preparation and use thereof |
08/11/2010 | CN101293876B Benzoxazole ketones derivative and preparation method thereof |
08/11/2010 | CN101229184B DNA degradation fragment compound and applications thereof |
08/11/2010 | CN101181103B Vegetable sponge massage health shoe for disinfecting and removing peculiar smell as well as producing method thereof |
08/11/2010 | CN101099852B Traditional Chinese medicine composition for treating chronic viral hepatitis and preparation method thereof |
08/11/2010 | CN101036684B Isatis-Root extractive and the purifying method and the medicine combination |
08/11/2010 | CN101036656B Stable cefoperazone tazobactam medicine compound preparation |
08/10/2010 | US7772386 immunization against Mycobacterium tuberculosis; purified nucleic acid molecule coding for oxidoreductase from M. tuberculosis; production of a vaccine against a virulent strain of M. tuberculosis |
08/10/2010 | US7772284 Administering organonitrogen polymers and optionally with mixtures of cyclodextrins, as viricides; enzyme inhibitors |
08/10/2010 | US7772260 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases |
08/10/2010 | US7772249 Imidazo[1,2-b]pyridazine compound |
08/10/2010 | US7772228 Administering a rifamycin microbiocides for treating infections caused by Mycobacterium tuberculosis, Mycobacterium avium complex, Chlamydia pneumoniae or Helicobacter pylori |
08/10/2010 | US7772226 such as 3-(2-Butynyl)-2-(piperazin-1-yl)-3,5-dihydroimidazo[4,5-d]pyridazin-4-one trifluoroacetate, used as dipeptidyl peptidase-IV (DPPIV) inhibitors for the treatment of obesity and diabetes |
08/10/2010 | US7772212 Isomaltooligosaccharides to inhibit avian pathogenic intestinal bacteria |
08/10/2010 | US7772194 Pesticidal formulations |
08/10/2010 | US7771982 lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions; lactobacilli, bifidobacteria or Enterococci |
08/10/2010 | US7771979 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
08/10/2010 | US7771963 Methods for determining efficacy of chemotherapeutic agents |
08/10/2010 | US7771927 Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region |
08/10/2010 | US7771743 Infection resistant polymers, their preparation and uses |
08/10/2010 | US7771729 Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors |
08/10/2010 | US7771728 Hyperimmune serum-reactive antigen for use in prevention and treatment of tumor, allergen or metabolic disorders |
08/10/2010 | CA2528818C Topical aerosol foams |
08/10/2010 | CA2487252C Esters in position 20 of camptothecins |
08/10/2010 | CA2451768C Peptoid compounds |
08/10/2010 | CA2440714C Pyrazolopyrimidines as therapeutic agents |
08/10/2010 | CA2419801C Steroid derived antibiotics |
08/10/2010 | CA2413809C Synergistic antiplaque/antigingivitis oral composition |
08/10/2010 | CA2391507C Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
08/10/2010 | CA2389647C Isoxazole derivatives as phosphodiesterase vii inhibitors |
08/10/2010 | CA2361617C Uses of thank, a tnf homologue that activates apoptosis |
08/10/2010 | CA2243235C Immunotherapy using cytotoxic t lymphocytes (ctl) |
08/10/2010 | CA2180032C Gene expression control |
08/05/2010 | WO2010088222A2 A high molecular weight polysaccharide that binds and inhibits virus |
08/05/2010 | WO2010087358A1 Novel composition |
08/05/2010 | WO2010087319A1 Method for screening substance useful as therapeutic agent for prostate cancer |
08/05/2010 | WO2010087260A1 Anti-tuberculosis agent and use thereof |
08/05/2010 | WO2010087244A1 Cyclic amino alcohol compound |
08/05/2010 | WO2010087131A1 Hiv replication inhibitor, and use thereof |
08/05/2010 | WO2010086617A2 Treatment |
08/05/2010 | WO2010086614A1 Treatment |
08/05/2010 | WO2010086445A1 Tslp promotes immune evasion and persistence of viruses |
08/05/2010 | WO2010085896A1 Compositions comprising chlamydia antigens |
08/05/2010 | WO2010066931A4 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug |
08/05/2010 | WO2010025380A3 Analysis of hcv genotypes |
08/05/2010 | WO2009142827A3 Compounds and methods for the treatment of viral infection |
08/05/2010 | WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
08/05/2010 | US20100199368 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis |
08/05/2010 | US20100197948 Inhibitors of yeast filamentous growth and method of their manufacture |
08/05/2010 | US20100197917 Coumarin derivatives useful as tnf alpha inhibitors |
08/05/2010 | US20100197907 Phosphorus-containing compounds & uses thereof |
08/05/2010 | US20100197804 Pharmaceutical compositions comprising terbinafine |
08/05/2010 | US20100197795 Transdermal compositions |
08/05/2010 | US20100197784 Novel curcumin analogues and uses thereof |
08/05/2010 | US20100197771 Influenza virus vaccine composition and methods of use |
08/05/2010 | US20100197768 Methods and compositions related to the structure and function of apobec3g |
08/05/2010 | US20100197761 Fused cyclic compounds |
08/05/2010 | US20100197734 Pleuromutilin derivatives and their use as antimicrobials |
08/05/2010 | US20100197727 Quinoline Derivatives as Antibacterial Agents |
08/05/2010 | US20100197721 PYRROLO [3, 4-h] ISOQUINOLINE COMPOUNDS AND METHODS FOR MODULATING GATED ION CHANNELS |
08/05/2010 | US20100197679 Compounds |
08/05/2010 | US20100197673 Indole and indazole compounds as an inhibitor of cellular necrosis |
08/05/2010 | US20100197672 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto |
08/05/2010 | US20100197671 Phenyl amino pyrimidine compounds and uses thereof |
08/05/2010 | US20100197653 Novel carbapenem derivatives |
08/05/2010 | US20100197650 Compositions and methods of treatment comprising ceftaroline |
08/05/2010 | US20100197649 Compositions and Methods for Diagnosing and Treating Community-Acquired Methicillin-Resistant Staphylococcus Aureus |
08/05/2010 | US20100197641 Formulation for lipophilic agents |
08/05/2010 | US20100197622 Non-Peptide Macrocyclic Histone Deacetylase (HDAC) Inhibitors and Methods of Making and Using Thereof |
08/05/2010 | US20100197621 Methods of reducing the proliferation and viability of microbial agents |
08/05/2010 | US20100197620 Pesticidal formulations |
08/05/2010 | US20100197619 Cyclin-dependent protein kinases inhibitors of scutellaria flavonoid organic amine derivatives, synthesis and use thereof |
08/05/2010 | US20100197616 Proliferation inhibitor of helicobacter pylori including alpha-n-acetyl-glucosaminyl bond-containing monosaccharide derivatives |
08/05/2010 | US20100197608 Use of melanotrophin-potentiating factor as a therapeutic agent |
08/05/2010 | US20100197606 Non-proteolysable oligopeptides that inhibit glycoprotein gp41 of the aids virus |
08/05/2010 | US20100197605 Therapeutic use of peptide yglf and combination with kvlpvpq |
08/05/2010 | US20100197604 Use of peptide as a therapeutic agent |
08/05/2010 | US20100197603 Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections |
08/05/2010 | US20100197602 Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infection |
08/05/2010 | US20100197601 Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection |
08/05/2010 | US20100197600 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh as a therapeutic agent |
08/05/2010 | US20100197599 Use of a peptide as a therapeutic agent |
08/05/2010 | US20100197591 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES |
08/05/2010 | US20100197588 Use of a peptide as a therapeutic agent |
08/05/2010 | US20100197587 Use of a peptide as a therapeutic agent |